PDB 3s85
PDB Information
PDB | 3S85 |
Method | X-RAY DIFFRACTION |
Host Organism | Escherichia coli |
Gene Source | Human immunodeficiency virus 1 |
Primary Citation | 2-Pyridyl P1'-substituted symmetry-based human immunodeficiency virus protease inhibitors (A-792611 and A-790742) with potential for convenient dosing and reduced side effects.
J.Med.Chem.
|
Header | Hydrolase/Hydrolase Inhibitor |
Released | 2011-05-27 |
Resolution | 2.800 |
CATH Insert Date | 27 May, 2012 |
PDB Images (25)
PDB Prints
PDB Chains (12)
Chain ID | Date inserted into CATH | CATH Status |
---|---|---|
A | 28 May, 2012 | Chopped |
B | 28 May, 2012 | Chopped |
C | 28 May, 2012 | Chopped |
D | 28 May, 2012 | Chopped |
E | 28 May, 2012 | Chopped |
F | 28 May, 2012 | Chopped |
G | 28 May, 2012 | Chopped |
H | 28 May, 2012 | Chopped |
I | 28 May, 2012 | Chopped |
J | 28 May, 2012 | Chopped |
K | 28 May, 2012 | Chopped |
L | 28 May, 2012 | Chopped |
CATH Domains (12)
Domain ID | Date inserted into CATH | Superfamily | CATH Status |
---|---|---|---|
3s85A00 | 08 Jun, 2012 | 2.40.70.10 | Assigned |
3s85B00 | 08 Jun, 2012 | 2.40.70.10 | Assigned |
3s85C00 | 08 Jun, 2012 | 2.40.70.10 | Assigned |
3s85D00 | 08 Jun, 2012 | 2.40.70.10 | Assigned |
3s85E00 | 08 Jun, 2012 | 2.40.70.10 | Assigned |
3s85F00 | 08 Jun, 2012 | 2.40.70.10 | Assigned |
3s85G00 | 08 Jun, 2012 | 2.40.70.10 | Assigned |
3s85H00 | 08 Jun, 2012 | 2.40.70.10 | Assigned |
3s85I00 | 08 Jun, 2012 | 2.40.70.10 | Assigned |
3s85J00 | 08 Jun, 2012 | 2.40.70.10 | Assigned |
3s85K00 | 08 Jun, 2012 | 2.40.70.10 | Assigned |
3s85L00 | 08 Jun, 2012 | 2.40.70.10 | Assigned |
UniProtKB Entries (12)
Accession | Gene ID | Taxon | Description |
---|---|---|---|
P12497 | POL_HV1N5 | Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE) | Gag-Pol polyprotein |
P12497 | POL_HV1N5 | Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE) | Gag-Pol polyprotein |
P12497 | POL_HV1N5 | Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE) | Gag-Pol polyprotein |
P12497 | POL_HV1N5 | Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE) | Gag-Pol polyprotein |
P12497 | POL_HV1N5 | Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE) | Gag-Pol polyprotein |
P12497 | POL_HV1N5 | Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE) | Gag-Pol polyprotein |
P12497 | POL_HV1N5 | Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE) | Gag-Pol polyprotein |
P12497 | POL_HV1N5 | Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE) | Gag-Pol polyprotein |
P12497 | POL_HV1N5 | Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE) | Gag-Pol polyprotein |
P12497 | POL_HV1N5 | Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE) | Gag-Pol polyprotein |
P12497 | POL_HV1N5 | Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE) | Gag-Pol polyprotein |
P12497 | POL_HV1N5 | Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE) | Gag-Pol polyprotein |